Hemp Opportunistic Investments LXIV Fund (Medical Marijuana Stocks)

Hemp Opportunistic Investments LXIV Fund (Medical Marijuana Stocks) The Hemp Farming Act of 2018 was a proposed law to remove hemp (defined as cannabis with less than 0.3% THC) from Schedule I controlled substances and making it an ordinary agricultural commodity. Its provisions were incorporated in the 2018 United States farm bill that became law on December 20, 2018. Prometheus Botany Medicinal is accepting membership interest in our opportunistic investments LXIV Fund include investments in Licensed Cannabis tracked-and-trace Businesses (the debt instruments of companies which may be publicly traded or privately held that are Cannabis Dispensary, Cannabis Cultivation, Cannabis Manufacturing, Cannabis Distribution, Cannabis Testing Laboratory, Facility, or Entity) and or Land Development, mezzanine, secondaries, and other private investment strategies that are opportunistic in nature and do not follow a buyout or venture capital/growth equity strategy. Click Here to Start Investing An investor will receive  shares of common stocks. Share prices are currently $0.16 each and require a minimum investment of $500 to $2,000 Investment returns will fluctuate and are subject to market volatility, so that an investor’s shares, when redeemed or sold, may be worth more or less than their original cost. Unlike mutual funds, shares of  Prometheus Botany Medicinal operated by series LLC MKG Financial Group Private Equity Fund Advisors Private Placements are not individually redeemable directly with the exchange market NASDAQ, S&P 500, Down Jones, OTC Markets Shares are bought and sold at par value, which may be higher or lower than the net asset value (NAV). Equity Crowd Funding Offering Memorandum: Not FDIC Insured • No Bank Guarantee • May Lose Value Become a (Medical Marijuana Stock) Investor